Sonoma Pharmaceuticals, Inc. (SNOA) Form 8-K — Oct 6, 2026
$SNOAForm 8-KItems 1.01, 3.03, 5.03, 9.01Filed Oct 6, 2026, 4:30 PM ET0001683168-26-007657Original filing
Sonoma Pharmaceuticals adopted a Section 382 rights agreement on October 6, 2026, with Computershare Inc. as rights agent, replacing its expiring 2016 rights plan. Each shareholder of record on October 13, 2026 receives one right per common share, exercisable for 1/1,000th of a Series B Preferred share at $10.00. The plan triggers if any person or group acquires 4.99% or more of common stock (existing 4.99%+ holders get a 0.5% grandfathered cushion), causing dilution to the acquirer via flip-in and flip-over provisions.
Key figures
- Record date
- 2026-10-13
- Formula number
- 1000
- Expiration date
- 2036-10-06
- Purchase price per right
- $10.00
- Acquiring person threshold
- 4.99%
- Redemption price per right
- $0.0001
- Series b authorized shares
- 100000
- Grandfathered increase trigger
- 0.5% above grandfathered percentage
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.